tiprankstipranks
VG Life Sciences Inc (VGLS)
OTHER OTC:VGLS
US Market

VG Life Sciences (VGLS) Financial Statements

17 Followers

VG Life Sciences Financial Overview

VG Life Sciences's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is -100.00; VG Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 15Jun 15Mar 15Dec 14Sep 14
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBIT$ -771.74K$ -975.22K$ -756.35K$ 233.14K$ -383.88K
EBITDA$ -771.74K$ -975.22K$ -756.35K$ 233.14K$ -383.88K
Net Income Common Stockholders$ -1.01M$ -1.40M$ -1.46M$ -424.50K$ -1.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 22.92K$ 4.33K$ 30.07K$ 33.99K$ 53.84K
Total Assets$ 1.12M$ 1.12M$ 1.17M$ 1.32M$ 1.14M
Total Debt$ 3.38M$ 4.09M$ 4.25M$ 3.86M$ 3.70M
Net Debt$ 3.36M$ 4.09M$ 4.22M$ 3.83M$ 3.64M
Total Liabilities$ 5.46M$ 5.96M$ 5.89M$ 5.83M$ 6.31M
Stockholders Equity$ -4.98M$ -5.49M$ -5.38M$ -5.17M$ -5.84M
Cash Flow-
Free Cash Flow$ -48.32K$ -237.56K$ -165.04K$ -407.41K$ -468.34K
Operating Cash Flow$ -48.32K$ -237.56K$ -165.04K$ -407.41K$ -468.34K
Investing Cash Flow--$ 0.00$ 0.00-
Financing Cash Flow$ 66.91K$ 211.83K$ 161.12K$ 387.56K$ 489.33K
Currency in USD

VG Life Sciences Earnings and Revenue History

VG Life Sciences Debt to Assets

VG Life Sciences Cash Flow

VG Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis